Tips for Hosting a Food-Allergy-Friendly Holiday Party
Cincinnati Children's Research Paves Way For Newly Approved Asthma Drug
A Family Journey
The CURED Conference brought together patient families, physicians, and researchers from across the globe to learn from each other. One of the most moving and memorable presentations was a patient perspective from Kara Root, whose story inspires us here at Cincinnati Children’s as well those across the eosinophilic gastrointestinal disorder (EGID) community. You can read more about Kara and her family’s journey on her blog.
Celebrating 140 Collective Years of Service of Allergy and Immunology at Cincinnati Children's
The Division of Allergy and Immunology is celebrating a unique year as six division faculty observe their 10-, 20-, 30-, and 40-year Cincinnati Children's service anniversaries! Their sustained contributions at multiple levels and their influence on past and future generations put the division in a strong position. Here, they offer insight into the changes they have been part of and where the division is going.
Environmental Factors Could Adjust Risk of Eosinophilic Esophagitis in People with Particular Gene Variants
Handy Checklist: Going to College with an Eosinophilic Gastrointestinal Disorder
Pushing for Progress in a Rare Eosinophilic Condition: Eosinophilic Gastritis
What's the right time to use an EpiPen?
Amal H. Assa'ad, MD comments about administering epinephrine auto-injectors for anaphylaxis in this news video.
Family Fights For Formula Coverage Despite it Being Illinois Law
In this NCB Chicago news segment, Marc E. Rothenberg, MD, PhD and professional and family colleagues comment about insurance coverage for medical formulas.
FARE Patient Registry
The FARE Patient Registry launched on May 22, 2017 and is a patient-powered research registry, created with collaboration by FARE’s Medical Advisory Board, members of the Outcomes Research Advisory Board and AltaVoice, a leading registry platform and expert in the field of online protection and privacy.
FDA-approved drug helps treat rare immunologic disease, study finds
The NIH reports on a phase 3 clinical trail that they co-funded and that tested mepolizumab (humanized antibody against IL-5) as an alternative treatment for an eosinophilic syndrome, eosinophilic granulomatosis with polyangiitis (EGPA; previously known as Churg-Strauss syndrome).
2017 FARE Research Retreat: Q&A with Dr. Simon Hogan
Simon P. Hogan, PhD, received a FARE Investigator in Food Allergy Award in 2015. With this support, the Hogan Lab is investigating how proteins released at the start of an allergic response can cause blood vessels to leak during life-threatening anaphylaxis. Understanding the chain of chemical events that leads to anaphylactic shock is a key step in devising strategies to prevent severe food allergy symptoms. Hogan presented at the FARE 2017 Research Retreat and explains his work in this Q&A on the FARE blog.
Poster of Distinction, Nutrition Research Day
Mark Rochman, PhD, and Carina Venter, PhD, RN, and their students, Rachel Ernst and Tarah Wagner won the Poster of Distinction at the Nutrition Research Day Poster Session at Cincinnati Children's for their work on peanut protein levels.Ernst and Wagner went on to take first place in the Agriculture / Food Science category at their high school's capstone competition on April 28.
Andrew W. Lindsley, MD, PhD was awarded a K08 from the National Institute of Allergy and Infectious Diseases (NIAID). This NIH clinical scientist career development award will support the Lindsley Lab in investigating how the sphingolipid ORMDL3 regulates dendritic cells in asthma.
NIH R01 and DHC Awards
Patricia C. Fulkerson, MD, PhD was awarded an R01 from National Institute of Allergy and Infectious Diseases (NIAID). This R01 will support the Fulkerson Lab in investigating the role of the transcription factor Aiolos in eosinophilic asthma. Learn more about her research in the Fulkerson Lab.
2017 AAAAI Annual Meeting Awards
For the 2017 American Academy of Asthma, Allergy & Immunology (AAAAI) Annual Meeting, our Cincinnati Children’s/University of Cincinnati College of Medicine colleagues presented over 50 presentations, which is an impressive number. This underscores the collective impact that Cincinnati Children’s/University of Cincinnati College of Medicine is having in our field. Dr. Justin Wheeler was the recipient for the award for the 2017 AAAAI/APFED Best Oral Abstract on eosinophilic gastrointestinal diseases by a fellow-in-training. Amnah Yamani, a predoctoral student in the Hogan Lab, was selected to be in the featured poster session. Amal H. Assa’ad, MD, was selected to give the first Leonard Bernstein Lectureship. This lectureship was established in memory of our legendary Dr. Leonard Bernstein, who was a pioneer in the allergy field, founder of the allergy discipline in Cincinnati and a wonderful mentor and contributor to our program. The lectureship was sponsored by donations from the Bernstein Family and Dr. Bernstein’s past trainees and colleagues.
FADDA Interest Section
Amal H. Assa’ad, MD, was elected by her peers to serve as the Secretary of the AAAAI’s Food allergy, anaphylaxis, dermatology and drug Allergy (FADDA) Interest Section from March 5, 2017 until March 2019. After the 2019 AAAAI Annual Meeting and until the 2021 Annual Meeting, she will serve in the role as the Vice Chair of the interest section, and then from 2021 until 2023, she will serve in the role of Chair of FADDA.
Clinical Care Award
Michelle B. Lierl, MD, was selected by The Faculty Awards Committee at Cincinnati Children's for the Clinical Care Award. This is a well-deserved honor for Dr. Lierl, who is now in her 30th anniversary year at Cincinnati Children's. In addition to her great clinical service, Dr. Lierl researches fungal allergens in the Lierl Lab and has created a fungal spore photo website.
2016 Division Research Advances Video
We invite you to watch a short video detailing a few of the Division of Allergy and Immunology’s Research Advances of 2016. Through our sustained commitment to research and clinical excellence for allergic and immunologic conditions, we will continue to change the outcome together.
CURED Foundation donates for Eosinophilic Disorder Treatment and Research
The Campaign Urging Research for Eosinophilic Disease (CURED), a not-for-profit foundation dedicated to those suffering from eosinophilic disorders, has donated $200,000 to the Cincinnati Center for Eosinophilic Disorders (CCED), based at Cincinnati Children’s Hospital Medical Center. The CURED Foundation works extensively in supporting families and raising funds for research. One-hundred percent of funds raised by the CURED Foundation go to research for eosinophilic disorders. To date, CURED has contributed over 4 million dollars to research.
2017 NIAID Addendum Guidelines for Preventing Peanut Allergy
In 2015, findings from a landmark NIAID-funded clinical trial called the Learning Early About Peanut (LEAP) study showed that introducing peanut-containing foods to infants at high risk for developing peanut allergy was safe and led to an 81% relative reduction in the subsequent development of peanut allergy. Due to the strength of these results, NIAID established a coordinating committee that convened an expert panel to update the 2010 Guidelines to specifically address the prevention of peanut allergy. Amal H. Assa'ad, MD, and Carina Venter, PhD, RD, contributed to the Addendum Guidelines for the Prevention of Peanut Allergy in the United States that were published in the January 2017 issue of Annals of Allergy and Immunology, along with a guest editorial by Amal H. Assa'ad, MD.
2017 AAAAI Distinguished Service Award
Well-deserved congratulations go to Kimberly A. Risma, MD, PhD, for being selected for the 2017 Distinguished Service Award of the American Academy of Asthma, Allergy & Immunology (AAAAI) for her leadership with the Chrysalis Project. The Chrysalis Project is a program for medical students and internal medicine and/or pediatric residents that provides them the opportunity to explore a career in allergy/immunology. It is housed within the AAAAI Annual Meeting and includes pairing the Chrysalis mentee with a fellow-in-training mentor, didactic lectures with allergy/immunology faculty, career option presentations, and free conference registration and access to the leading knowledge in the hundreds of AAAAI meeting sessions, workshops, symposia, seminars, and oral abstracts. Dr. Risma has helped to propel this program to become a jewel of our society and is thus greatly impacting our field and its future. Through her efforts, she has established a ‘pipeline’ of strong physicians in our field. In 2010, Dr. Risma was nominated by the Board of AAAAI to assume the co-Chair position of the Chrysalis Program Project after a pause in the program’s funding. She has subsequently worked tirelessly on the Chrysalis Project with current AAAAI president, Dr. Tom Fleisher between 2010-15 and former AAAAI president, Dr. Wesley Burks in 2015-17. Under her leadership, the program has expanded from 20 to 50 attendees per year. The Chrysalis Project has been extraordinarily well received as is evident from the growing number of highly qualified applicants and attendees, the positive reviews, and the growing number of fellowship applicants who credit the Chrysalis Project.